Credo's Optical Pivot Narrative Clashes with Filing Realities

What happened

Credo Technology has surged on hyperscaler-driven revenue growth, but SEC filings reveal extreme customer concentration and a guided gross margin reset. A Seeking Alpha article highlights Credo's transition to a vertically integrated optical platform via the DustPhotonics acquisition, targeting over $500 million in optical revenue by FY27. However, the company's latest 10-Q shows two customers accounted for 87% of Q3 FY26 revenue, with minimal contracted backlog and inventory ballooning to $208 million. Management's Q4 FY26 guidance includes a gross margin drop to 64-66%, contrasting with the article's optimistic portrayal of durable high margins. This disconnect underscores that while the optical pivot aims to diversify long-term growth, near-term risks from concentration and margin volatility remain stark.

Implication

Credo's high valuation at ~24x forward P/S prices in flawless execution, leaving no margin of safety if revenue misses or margins deteriorate further. The optical pivot may offer future diversification, but near-term results hinge on a few hyperscaler programs with limited contractual visibility. Monitoring Q4 FY26 for revenue within $425-435 million and gross margin at 64-66% is critical to assess durability against guided expectations. Any inventory write-downs or persistent concentration in upcoming filings would signal heightened risk of earnings compression. Until evidence of sustained growth and margin stability emerges, a wait-and-see approach mitigates exposure to potential downside from these vulnerabilities.

Thesis delta

The new article introduces an optical growth narrative that could enhance Credo's long-term prospects, but it does not alter the DeepValue report's core thesis. Investors must still wait for proof that revenue remains sequentially durable and margins stabilize, as concentration risks and inventory build-up persist unchanged. The optical pivot is a strategic hedge, but it fails to address near-term execution hurdles that could break the investment case.